Otsuka Holdings
4578.T
#921
Rank
$18.15 B
Marketcap
$33.47
Share price
-2.87%
Change (1 day)
-6.38%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2022 (TTM): $1.09 B

According to Otsuka Holdings 's latest financial reports the company's current earnings (TTM) are $1.09 B. In 2021 the company made an earning of $1.52 B a decrease over its 2020 earnings that were of $1.90 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$1.09 B-27.96%
2021$1.52 B-19.69%
2020$1.90 B13.78%
2019$1.67 B52.66%
2018$1.09 B10.93%
2017$0.98 B-33.41%
2016$1.48 B26%
2015$1.17 B
2013$2.44 B33.73%
2012$1.82 B-4.78%
2011$1.92 B45.1%
2010$1.32 B